Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study

Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural disorders and mild cognitive impairment. The objective of this double-blind randomised placebo-controlled trial was to study the efficacy and tolerance of topiramate on behavioural disorders in patients with PWS. Pa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transl Psychiatry
Auteurs principaux: Consoli, Angèle, Çabal Berthoumieu, Sophie, Raffin, Marie, Thuilleaux, Denise, Poitou, Christine, Coupaye, Muriel, Pinto, Graziella, Lebbah, Said, Zahr, Noel, Tauber, Maïthé, Cohen, David, Bonnot, Olivier
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6828670/
https://ncbi.nlm.nih.gov/pubmed/31685813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-019-0597-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires